Cellcolabs vs PFx Biotech

Cellcolabs vs PFx Biotech, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Cellcolabs is on 55/100 and PFx Biotech on 51/100.

Cellcolabs logo
CellcolabsAI-powered platform for personalized cell therapy development and manufacturing.
Try Cellcolabs
PFx Biotech logo
PFx BiotechPFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.
Try PFx Biotech

Where each one leads

Cellcolabs

  • our overall score: 55/100 against 51/100
  • domain rating: 37/100 against 17/100
  • headcount: 79 against 9
  • funding raised: $15.5M against $5.2M
  • LinkedIn following: 6,563 against 3,138

PFx Biotech

Leads on none of the measures we hold for both companies.

At a glance

MeasureCellcolabsPFx Biotech
What it isAI-powered platform for personalized cell therapy development and manufacturing.PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.
CategoryBiotech, MedTech, HealthTech, Drug DiscoveryBiotech, Drug Discovery, Genomics, AI-Driven Protein Design
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded20212017
HeadquartersTel Aviv, IsraelCambridge, United States
StatusActiveActive

Size, funding and growth

MeasureCellcolabsPFx Biotech
Employees799
Total funding$15.5M$5.2M
LinkedIn followers6,5633,138

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureCellcolabsPFx Biotech
StartupHub scoreOur 0-100 rating55/10051/100
TractionNot published44/100
TeamNot published60/100
Search visibility2/10029/100
QualityNot published58/100
Agent readinessHow well an AI agent can read and act on the siteD (40/100)D (44/100)
Domain ratingLink authority, 0-10037/10017/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureCellcolabsPFx Biotech
CDNCloudflareCloudflare
AnalyticsGoogle Tag ManagerNot detected
Open sourceNoYes

Cellcolabs vs PFx Biotech: common questions

Which is better, Cellcolabs or PFx Biotech?

On our 0-100 score Cellcolabs rates higher (55/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.

How do Cellcolabs and PFx Biotech compare on the numbers?

Cellcolabs leads on our overall score (55/100 against 51/100), domain rating (37/100 against 17/100), headcount (79 against 9), funding raised ($15.5M against $5.2M), LinkedIn following (6,563 against 3,138).

Read the full Cellcolabs review and pricing or the PFx Biotech review and pricing. You can also browse other Cellcolabs alternatives we track.